ACE Inhibition Is Renoprotective among Obese Patients with Proteinuria

Obesity may increase the risk for progression of CKD, but the effect of established renoprotective treatments in overweight and obese patients with CKD is unknown. In this post hoc analysis of the Ramipril Efficacy In Nephropathy (REIN) trial, we evaluated whether being overweight or obese influence...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Mallamaci, Francesca, Ruggenenti, Piero, Perna, Annalisa, Leonardis, Daniela, Tripepi, Rocco, Tripepi, Giovanni, Remuzzi, Giuseppe, Zoccali, Carmine
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Nephrology 2011
Fag:
Clinical Epidemiology
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3103731/
https://ncbi.nlm.nih.gov/pubmed/21527660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2010090969
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker